Corporate
News

LR Health & Beauty SE advances strategic realignment

• Strategic initiatives over the course of 2026 to provide tangible impetus for partners’ business activities 
• Initiatives supported by financially strong investors

Ahlen, 6 March 2026 – LR Health & Beauty SE, Europe’s leading social commerce company in the area of high-quality health and beauty products, is taking the next step in its financial realignment. To this end, the Company today entered into further agreements that enable the company to implement targeted strategic initiatives for a sustainable positive business development.

Jörg Körfer, Chief Executive Officer (CEO) of LR Health & Beauty SE, explains: “The injection of fresh capital will advance our strategic realignment. In this respect, we are pleased to have financially strong partners at our side which secure and strengthen LR’s long-term financial stability and investment capacity. This will create the conditions for launching further targeted strategic initiatives in 2026. In April, our Business Days will be held with several thousand distribution partners. We will take this opportunity to present a promising product launch in the health and beauty area and further advance business with our partners. We will also inform our partner community about exciting news regarding our sales competitions and the LR car concept with the latter receiving its own showroom where partners will be able to celebrate the car handover in the future.”

In order to align business processes with future growth, LR is focusing, among other things, on inhouse production of selected products and efficiency enhancements through greater vertical integration. Accordingly, preparations are under way for the in-house production of an attractive top-selling product from the portfolio in order to benefit from improved scalability and flexibility. The project launched for this purpose is supported by the German Federal Ministry of Research, Technology and Space (BSFZ). The BSFZ supports projects that demonstrate a high level of entrepreneurial innovation capability.

LR Group

Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.

Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.

The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.

In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.

Contact:

PR Contact: 
LR Health & Beauty SE    
Almut Kellermeyer     
Head of Corporate Communication     
Kruppstraße 55    
59227 Ahlen    
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/

IR Contact: 
cometis AG
Thorben Burbach 
Unter den Eichen 7 | Building D 
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de

LR Health & Beauty SE publishes Q4 2025 report and advances financial and strategic initiatives

• FY 2025 sales reached EUR 277.1 million on a preliminary basis, with EBITDA reported of EUR 16.5 million 
• Focus on implementing a new financing structure and initiating targeted strategic measures for long-term business development and growth 
• Planned launch of new generation of products combining health and beauty expertise demonstrates innovative strength and sets important impulses for 2026

Ahlen, 24 February 2026 – LR Health & Beauty SE, Europe’s leading digital social commerce company for high-quality nutritional supplements and beauty products, today publishes its results for the fourth quarter of 2025 as well as preliminary sales and earnings results for the 2025 financial year.

The LR Group continued to face generally subdued consumer sentiment in Western European markets in the fourth quarter of 2025. LR Health & Beauty SE achieved sales (revenue from goods sold) of EUR 68.2 million in the fourth quarter 2025 (Q4 2024: EUR 76.5 million), representing a decrease of 10.9%. Accordingly, over the course of the full 2025 year, LR Health & Beauty SE posted a 4.6% year-on-year lower level of sales of EUR 277.1 million on a preliminary basis (2024: EUR 289.2 million).  

Furthermore, LR Health & Beauty SE achieved EBITDA reported of EUR 0.3 million in the fourth quarter of 2025 (Q4 2024: EUR 8.3 million). The results in the final quarter were particularly affected by the lower sales level and exceptional items as part of the realignment of the financing structure. For the full 2025 year, reported EBITDA on a preliminary basis amounted to EUR 16.5 million compared with EUR 27.3 million in 2024. Normalized EBITDA in the fourth quarter of 2025 decreased to EUR 3.4 million, compared with EUR 9.5 million in the fourth quarter of the previous year. Accordingly, over the full course of 2025, normalized EBITDA amounted to EUR 22.5 million on the basis of preliminary figures (2024: EUR 32.6 million). 

Jörg Körfer, CEO of LR Health & Beauty SE, comments: “In both financial and strategic terms, we are focusing consistently on creating the preconditions for sustainably positive business growth. We have recently reached an important milestone with the agreement concerning a realignment of the financing structure. At the same time, it is important in 2026 to advance the LR Group’s business with suitable strategic initiatives. One focus in this context is the further development of our product portfolio. In the spring, we are planning the promising launch of a new generation of products that combines expertise from the health and beauty areas and will provide our distribution partners with fresh impetus for their business activities.” 

In developing high-quality dietary supplements and cosmetic products, LR regularly draws on the latest findings from science and research. Sustainability aspects are also given special consideration when optimising the product portfolio – including in the upcoming product launch. 

The report for the fourth quarter of 2025 is available online from today on the company’s website at https://ir.lrworld.com/. The final, audited results for the 2025 financial year will be published at the end of April 2026 with the Annual Report on the company’s website.

LR Group

Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.

Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.

The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.

In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.

Contact:

PR Contact: 
LR Health & Beauty SE    
Almut Kellermeyer     
Head of Corporate Communication     
Kruppstraße 55    
59227 Ahlen    
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/

IR Contact: 
cometis AG
Thorben Burbach 
Unter den Eichen 7 | Building D 
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de

LR Health & Beauty SE lays foundation for positive future business performance with new financing structure 

• Company receives EUR 20 million of new capital and significantly reduces debt 
• Sustainable financing structure creates basis to implement targeted strategic measures to consistently drive LR’s success story 

Ahlen, 11 February 2026 – LR Health & Beauty SE, Europe’s leading social commerce company for high-quality nutritional supplements and beauty products, has today taken an important step to realign its financing structure. An agreement was reached with significant investors in the Company concerning a comprehensive restructuring of its 2024/2028 Bond (ISIN: NO0013149658) (the “Bond”) and the Company’s capital structure. This agreement provides for an aggregate injection of fresh capital of EUR 20 million. At the same time, the Company's debt structure is being significantly reduced and restructured.

Jörg Körfer, Chief Executive Officer of LR Health & Beauty SE, comments: “With this agreement on a realignment of our financing structure, we have reached an important milestone to reposition the LR Group to make it viable for the future. On the basis of a solid financing structure, we aim to initiate targeted strategic measures to now bring the LR Group onto a successful trajectory. The consistent digitalisation of our business processes, a focused further development of our product portfolio and our expansion into new markets are to play a central role in this context. Furthermore, our strong partner community represents an important foundation for the future success of our Company. Following the successful start-of-year events and the launch of an innovative new product under the LR Body Mission brand, we aim to create additional incentives for our partners' activities in the course of the year with promising product innovations.” 

LR Group

Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.

Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.

The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.

In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.

Contact:

PR Contact: 
LR Health & Beauty SE    
Almut Kellermeyer     
Head of Corporate Communication     
Kruppstraße 55    
59227 Ahlen    
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/

IR Contact: 
cometis AG
Thorben Burbach 
Unter den Eichen 7 | Building D 
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de

Denna kallelse till obligationsinnehavarna är endast utformad på engelska.

Stockholm, 11 February 2026
To the Bondholders in:
ISIN: NO0013149658 – LR Health & Beauty SE EUR 130,000,000 Senior Secured Callable Floating Rate Bonds 2024/2028

NOTICE TO BONDHOLDERS REGARDING RESTRUCTURING AND BACKSTOP PARTICIPATION

Nordic Trustee & Agency AB (publ) acts as agent (the “Agent”) for the holders of the bonds (the “Bondholders”) in the above mentioned bond issue NO0013149658 with an aggregated amount outstanding of EUR 130,000,000 (the “Bonds”) issued by LR Health & Beauty SE (the “Issuer”). 
All capitalised terms used herein and not otherwise defined in this notice shall have the meanings assigned to them in the terms and conditions of the Bonds as amended and/or restated from time to time.
The Agent has been informed by the Issuer that the Issuer has entered into an agreement (the “Agreement”) with Bondholders representing more than two thirds (2/3) of the Outstanding Nominal Amount of the Bonds as well as the Issuer’s shareholder regarding a comprehensive restructuring of the Bonds and the Issuer’s capital structure. 
The restructuring comprises an aggregate equity and debt injection of EUR 20 million in new capital, consisting of a (i) EUR 10 million equity contribution of which EUR 7.5 million shall be provided by the Bondholders (the “Share Issue”) and (ii) EUR 10 million in New Money Senior Bonds (as defined below).
The Issuer’s debt structure will be significantly downsized and restructured as follows:

• Senior secured debt of EUR 62.5 million comprising of the following tranches which will rank pari passu with each other and carry a fixed cash interest of 6.75% per annum:
  • EUR 10 million new money senior bonds (the “New Money Senior Bonds”), to be subscribed for in cash by Bondholders (offered pro rata to all Bondholders).
  • EUR 20 million reinstated elevated bonds (the “Reinstated Elevated Bonds”), allocated pro rata to Bondholders who participate in the New Money Senior Bonds.
  • EUR 32.5 million reinstated bonds (the “Reinstated Bonds”), allocated pro rata to all existing Bondholders. 
• Unsecured subordinated junior bonds of EUR 27.5 million (the “Junior Bonds”), allocated pro rata to all existing Bondholders, with payment-in-kind interest stepping up linearly from 6% per annum year one to 10% per annum year five, maturing in 2031.
• The part of the nominal amount of the Bonds (including accrued interest thereunder) that is not reinstated into Reinstated Elevated Bonds, Reinstated Bonds or Junior Bonds shall be written off in its entirety.

The New Money Senior Bonds and the equity contribution under the Share Issue will be fully backstopped by certain major Bondholders (such backstop providers being the “Original Backstop Providers”, and each backstop provider being a “Backstop Provider”) who have committed to subscribe for any portion of the New Money Senior Bonds and shares in the Share Issue not taken up by other Bondholders exercising their pro rata subscription rights, thereby ensuring that the restructuring is fully funded. Each Backstop Provider's undertakings shall be pro rata in relation to the amount of its pro rata share of the total amount of Bonds held by all Backstop Providers, for the amount that New Money Senior Bonds and/or shares in the Share Issue are not subscribed for by holders of Bonds pursuant to their pro rata subscription rights.
Bondholders who are not already committed as Backstop Providers may elect to become Backstop Providers in relation to one or both of the New Money Senior Bonds and equity contribution in the Share Issue by notifying the Agent’s legal counsel in accordance with the procedure set out below. To qualify as a Backstop Provider, a Bondholder must hold Bonds with a total Nominal Amount of a minimum of EUR 100,000 and no later than 23:00 (CET) on 16 February 2026:

• be a party to the Agreement (either as an original party or by acceding thereto);
• confirm in which of the New Money Senior Bonds and the Share Issue the Bondholder intends to participate as a Backstop Provider (the “Backstop Confirmation”);
• provide proof of holdings in respect of the Bonds held by such Bondholder (the “Proof of Holding”); and
• provide proof of funds covering no less than an amount calculated as set out below (the “Proof of Funds”, jointly with the Backstop Confirmation and the Proof of Holdings, the “Backstop Provider Confirmations”).
  The required Proof of Funds will be calculated as (i) the relevant holder of Bonds’ pro rata share of the New Money Senior Bonds and/or Share Issue based on its pro rata share of the Bonds (the “Pro Rata Share”) plus (ii) the relevant holder of Bonds’ maximum proportionate share of the EUR 20 million total backstop amount (the “Backstop Share”). Each of the Pro Rata Share and Backstop Share shall be calculated as set out below, such calculations to be provided together with the Proof of Funds by any holder of Bonds’ who intends to participate as a Backstop Provider.
  
  Pro Rata Share Formula : Pro Rata Share = (Bond Holding / 130,000,000) × 20,000,000
  Backstop Share Formula : Backstop Share = (Bond Holding / (60,443,000 + Bond Holding)) × 20,000,000
  Example calculated on the basis of a Bondholder holding Bonds with an aggregate Nominal Amount EUR 6,000,000:
  Pro Rata Share: (6,000,000 / 130,000,000) × 20,000,000 = EUR 923,077    
  Backstop Share: (6,000,000 / 66,443,000) × 20,000,000 = EUR 1,806,059    
  Total Proof of Funds: EUR 923,077 + EUR 1,806,059 = EUR 2,729,136

A Bondholder shall only be permitted to participate as a Backstop Provider if it participates with the full amount of the Bonds it holds and shall not be permitted to limit its backstop undertaking.
In its capacity as Agent and at the request of the Issuer, the Agent hereby gives notice to the Bondholders that any Bondholders who wish to participate in the restructuring as Backstop Providers shall notify the Agent’s legal counsel, Roschier Advokatbyrå AB, by email to Carl.Broden@roschier.com, axel.thorn-kock@roschier.com and Kelvin.Bortey.Ekenkrantz@roschier.com no later than 23:00 CET on Monday 16 February and provide sufficient information and/or evidence in respect of each of the Backstop Provider Confirmations and, if applicable, request to accede to the Agreement.
______________________________________________
Stockholm, 11 February 2026
NORDIC TRUSTEE & AGENCY AB (PUBL)
as Agent

LR Health & Beauty SE: Written Procedure under the 2024/2028 Bonds has been successfully concluded

Ahlen, 28 November 2025 – On 14 November 2025, LR Health & Beauty SE (the “Company”) initiated a written procedure under the terms and conditions for the Company’s 2024/2028 bonds (ISIN: NO0013149658) (the “Bonds”) to request certain temporary waivers relating to postponement of interest payments and non-compliance with the maintenance test (including the leverage covenant) for a period up to and including 28 February 2026 (the “Written Procedure”).

Deadline for voting in the Written Procedure was 15:00 hrs CET today. Votes representing a sufficient part of the adjusted nominal amount of the Bonds were obtained in order to form a quorum and a requisite majority of the adjusted nominal amount voted in favour of the temporary waivers in the Written Procedure.

The agent under the Bonds has further confirmed that the conditions set out in section 4 (Effectiveness) in the notice of the Written Procedure have been fulfilled. Consequently, the temporary waivers are effective immediately.

For further information regarding the Written Procedure, please refer to the notice of the Written Procedure which is accessible on the Company’s website at https://ir.lrworld.com/en/bond/.

LR Group

Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.

Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.

The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.

In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.

LR currently has around 1,200 employees and hundreds of thousands of registered community members.

Contact:

PR Contact: 
LR Health & Beauty SE    
Almut Kellermeyer     
Head of Corporate Communication     
Kruppstraße 55    
59227 Ahlen    
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/

IR Contact: 
cometis AG
Thorben Burbach 
Unter den Eichen 7 | Building D 
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de

Denna kallelse till obligationsinnehavarna är endast utformad på engelska. 

Stockholm, 28 November 2025 

To the Bondholders in: 
ISIN: NO0013149658 – LR Health & Beauty SE EUR 130,000,000 Senior Secured Callable Floating Rate Bonds 2024/2028 

NOTICE OF RESULTS OF WRITTEN PROCEDURE UNDER THE TERMS AND CONDITIONS 

Nordic Trustee & Agency AB (publ) acts as agent (the “Agent”) for the holders of the bonds (the “Bondholders”) in the above mentioned bond issue NO0013149658 with an aggregated amount outstanding of EUR 130,000,000 (the “Bonds”) issued by LR Health & Beauty SE (the “Issuer”). 

All capitalised terms used herein and not otherwise defined in this notice shall have the meanings assigned to them in the terms and conditions of the Bonds as amended and/or restated from time to time (the “Terms and Conditions”). 

Reference is made to the notice of written procedure dated 14 November 2025 (the “Written Procedure” and the “Notice of Written Procedure”) and the request for certain temporary waivers set out therein (the “Temporary Waivers”). 

Votes representing a sufficient part of the Adjusted Nominal Amount of the Bonds have been obtained in order to form a quorum and a requisite majority of the Adjusted Nominal Amount voted in favour of the Temporary Waivers in the Written Procedure. 

The conditions set out in section 4 (Effectiveness) in the Notice of the Written Procedure have been fulfilled. 

In its capacity as Agent, the Agent hereby gives notice to the Bondholders that the Written Procedure has been concluded and that the Temporary Waivers have become effective. 
______________________________________________ 
Stockholm, 28 November 2025 
NORDIC TRUSTEE & AGENCY AB (PUBL) 
as Agent

LR Health & Beauty SE publishes final results for the third quarter of 2025

• Preliminary figures for Q3/9M 2025 confirmed: sales for 9M 2025 at EUR 208.8 million, EBITDA reported at EUR 16.3 million
• Focus on initiatives to optimise business processes and sustainably improve the capital and financing structure
• Forecast for the 2025 financial year confirmed

Ahlen, 28 November 2025 – LR Health & Beauty SE, Europe’s leading digital social commerce company for high-quality nutritional supplements and beauty products, today published its final results for the third quarter of 2025 and the first nine months of 2025, thereby confirming the preliminary figures announced on 24 October 2025.

In the third quarter of the 2025 financial year, LR Health & Beauty SE generated sales (revenue from goods sold) of EUR 66.0 million (previous year: EUR 69.4 million), bringing sales for the first nine months of 2025 to EUR 208.8 million (previous year: EUR 212.7 million). While market conditions in many regions remained characterized by weak consumer sentiment, two newly launched fragrance collections provided positive momentum in September.

EBITDA reported for the third quarter of 2025 amounted to EUR 2.9 million (Q3 2024: EUR 7.3 million), primarily impacted by lower sales and higher marketing and sales expenses. Consequently, EBITDA reported for the first nine months of 2025 came in at EUR 16.3 million (9M 2024: EUR 19.0 million). The normalized EBITDA reached EUR 3.8 million in the third quarter of 2025 (Q3 2024: EUR 8.7 million) and EUR 19.1 million for the nine-month period (9M 2024: EUR 23.1 million).

Outlook

Jörg Körfer, Chief Executive Officer (CEO) of LR Health & Beauty SE, commented:
“Our priority is to position the LR Group on a robust operational and financial footing for the future. In this context, we will develop a clear action plan to establish a solid financial base and strengthen the competitiveness of the LR Group through targeted strategic initiatives. Despite the current challenging market environment, we continue to see attractive potential in our product segments, which we intend to address even more effectively going forward.”

Based on the final results for the third quarter of 2025, LR confirms the sales and earnings guidance for the full year 2025 that was adjusted in October 2025. Accordingly, sales (revenue from goods sold) for the 2025 financial year are still expected to be in the range of EUR 276 million to EUR 281 million, and EBITDA reported is expected to remain between EUR 17.0 million and EUR 20.0 million.

LR Group

Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.

Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.

The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.

In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.

LR currently has around 1,200 employees and hundreds of thousands of registered community members.

Contact:

PR Contact: 
LR Health & Beauty SE    
Almut Kellermeyer     
Head of Corporate Communication     
Kruppstraße 55    
59227 Ahlen    
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/

IR Contact: 
cometis AG
Thorben Burbach 
Unter den Eichen 7 | Building D 
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de

LR Health & Beauty SE initiates a Written Procedure under its outstanding 2024/2028 Bonds  

Ahlen, 14 November 2025 – LR Health & Beauty SE (the “Company”) announced on 20 October 2025 that the board of the Company identified an expected breach of the leverage covenant requiring the Company to maintain a ratio of net debt to EBITDA of 4.50:1 as at 30 September 2025 (the “Leverage Covenant”) under the terms and conditions (the “Terms and Conditions”) of the 2024/2028 bonds (ISIN: NO0013149658) (the “Bonds”).

Today, the board of the Company decided to initiate a written procedure (the “Written Procedure”) among the holders of the Bonds (the “Bondholders”) in accordance with the Terms and Conditions. 

For the period up to and including 28 February 2026, the Bondholders shall consent to temporarily waive any breach and/or event of default resulting from any (i) non-compliance with the maintenance test (including any potential breach of the Leverage Covenant), and (ii) postponement of interest payments under the Bonds due in November 2025 and February 2026 until such later date as will be set out in a restructuring proposal, provided that such date is approved by the Bondholders. A notice of the Written Procedure, including voting instructions, has today been sent by the agent under the Terms and Conditions to the direct registered owners and registered authorised nominees of the Bonds.

The last day for voting in the Written Procedure is 28 November 2025 and the voting record date is 17 November 2025. The Written Procedure may however be terminated before the expiry of the time period for replies if a requisite majority has been obtained.
The notice of the Written Procedure and further details are accessible on the Company’s website at https://ir.lrworld.com/en/bond/.

LR Group

Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.

Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.

The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.

In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.

LR currently has around 1,200 employees and hundreds of thousands of registered community members.

Contact:
PR Contact: 
LR Health & Beauty SE    
Almut Kellermeyer     
Head of Corporate Communication     
Kruppstraße 55    
59227 Ahlen    
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/

IR Contact: 
cometis AG
Thorben Burbach 
Unter den Eichen 7 | Building D 
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de

LR Health & Beauty SE reports on business development in the third quarter of 2025

• Sales of EUR 66.0 million in the third quarter of 2025; EUR 208.8 million in the first nine months of 2025
• EBITDA reported of EUR 2.9 million in the third quarter of 2025; EUR 16.3 million in the first nine months of 2025
• Successful relaunch of the fragrance segment and a well-stocked product pipeline create additional business opportunities for LR distributors
• Focus on developing an action plan with suitable measures to sustainably improve the capital and financing structure
• Sales and earnings guidance for fiscal year 2025 revised again

Ahlen, October 24, 2025 – LR Health & Beauty SE, Europe's leading digital social commerce company for high-quality nutritional supplements and beauty products, provides preliminary information on its business development in the third quarter of 2025 and in the first nine months of 2025. In the third quarter of the 2025 financial year, LR Health & Beauty SE generated sales (revenue from goods sold) of EUR 66.0 million according to preliminary figures, which corresponds to a decline of 5.0% compared to the corresponding quarter of the previous year (previous year: EUR 69.4 million). In the first nine months of 2025, sales amounted to EUR 208.8 million representing a decrease of 1.8% compared with the prior-year figure of EUR 212.7 million. The generally subdued consumer sentiment in the Western European markets also had a noticeable impact on the LR Group's business in the third quarter. By contrast, positive momentum has already come from the two new collections in the fragrance portfolio, which were successfully launched onto the market in September.

On the earnings side, based on preliminary figures, the company generated EBITDA reported of EUR 2.9 million in the third quarter of 2025. The significant decline of 59.9% compared to the previous year (Q3 2024: EUR 7.3 million) is mainly due to the lower sales and increased costs in the areas of marketing and sales. As a result, for the first nine months of 2025, EBITDA reported amounts to EUR 16.3 million (9M 2024: EUR 19.0 million). In addition, normalized EBITDA reached EUR 3.8 million in the third quarter of 2025 (Q3 2024: EUR 8.7 million) and EUR 19.1 million on a nine-month basis (9M 2024: EUR 23.1 million).

Jörg Körfer, CEO of LR Health & Beauty SE, explains: "In a market environment still characterized by high uncertainty and restrained consumer spending, we focus on deliberately strengthening the operating performance of the LR Group. The continuous optimisation and expansion of our product portfolio – most recently through the successful market launch of innovative fragrance lines – is an important strategic pillar. In addition, we want to align our processes even more closely with the needs of our distributors. The successfully conducted Business Days in September once again made it clear that together with our strong partner community, we can accomplish a great deal and make even better use of the potential in our business areas."

Expansion of the product portfolio

To mark its 40th anniversary, LR has realigned its fragrance portfolio and responds to consumer demand for particularly high-quality fragrance experiences with two new collections. The LR MOOD INFUSION line comprises 18 fragrances based on a patented mood technology and incorporates the latest scientific findings on the intensification of emotions. The second collection, LR ICONIC ELIXIRS, consists of four luxury perfumes that use rare essences such as Egyptian jasmine to create exceptional intensity and character. Both product lines feature improved formulas, high-quality packaging and the highest "Made in Germany" quality standards. In addition, LR has a well-stocked product pipeline to further complement the portfolio with suitable products and open up additional business opportunities for LR distribution partners.

Forecast 2025

In view of the challenging business development in the third quarter of 2025 and initiatives to secure sustainable financing for the LR Group, the Management Board has once again reassessed sales and earnings expectations. The Management Board now expects sales (revenue from goods sold) to be in the range of EUR 276 million to EUR 281 million for the full year 2025. Previously, sales were forecast to remain stable compared with the previous year (2024: EUR 289.2 million). EBITDA reported for the 2025 financial year is now expected to be between EUR 17.0 million and EUR 20.0 million, whereas the previous forecast was for EBITDA reported between EUR 24.0 million and EUR 27.0 million. In the fourth quarter of 2025, one-time effects in the low single-digit million euro range are expected to weigh on earnings in connection with initiatives to sustainably improve the financing situation.

"Our mission is clear: We want to make the LR Group operationally and financially sustainable for the future. From a financial point of view, we are in talks with the bond creditors of the 2024/2028 bond and have commissioned a restructuring report for support. This is intended to assist to develop an appropriate action plan for the company and to improve the capital and financing structure of the LR Group sustainably with appropriate measures," says Jörg Körfer, CEO of LR Health & Beauty SE.

LR Group

Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.

Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence.

The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe.

In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.

LR currently has around 1,200 employees and hundreds of thousands of registered community members.

Contact:

PR Contact: 
LR Health & Beauty SE    
Almut Kellermeyer     
Head of Corporate Communication     
Kruppstraße 55    
59227 Ahlen    
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/

IR Contact: 
cometis AG
Thorben Burbach 
Unter den Eichen 7 | Building D 
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de

LR Health & Beauty SE publishes figures for the first half of 2025 and adjusts its forecast for 2025

• EUR 142.9 million in sales achieved in the first half of 2025
• EBITDA reported improved by 13.6% to EUR 13.3 million
• Newly appointed management team with CEO Jörg Körfer and Interim CFO Ante Franicevic drives further development of corporate strategy
• Planned discussions with bondholders of the 2024/2028 bond regarding a precautionary resolution on a waiver of compliance with the Leverage Covenant as at 30 September 2025 and an amendment to the bond terms
• Sales and earnings guidance for financial year 2025 adjusted 

Ahlen, 28 August 2025 – LR Health & Beauty SE, Europe’s leading digital social commerce company for high-quality nutritional supplements and beauty products, today published its results for the second quarter and the first half of 2025. In the second quarter of the financial year 2025, LR Health & Beauty SE generated sales (revenue from goods sold) of EUR 68.9 million (Q2 2024: EUR 70.7 million) – a decline of 2.6%. In the first half of the year, sales amounted to EUR 142.9 million, representing a slight decrease of 0.3% compared with the prior-year figure of EUR 143.3 million. This development reflects the generally subdued consumer sentiment, particularly noticeable in Western European markets.

In addition, LR Health & Beauty SE achieved EBITDA reported of EUR 13.3 million in the first six months of 2025, representing a significant increase of 13.6% compared with the prior-year period (H1 2024: EUR 11.7 million). In the prior-year period, refinancing costs incurred in connection with the redemption of the previous bond had weighed on earnings. Normalized EBITDA increased by 6.3% to EUR 15.3 million in the first half of 2025 (H1 2024: EUR 14.4 million).

Valdemaras Gordinskis, Vice President Global Controlling and Investor Relations LR Health & Beauty SE, comments: “In the first half of 2025, we focused on further enhancing the foundations for the business success of our distributors. Our product innovations play an important role in this. Through regular product launches and the targeted expansion of our portfolio, we are opening up attractive business opportunities for our distributors in a generally challenging market environment.”

New leadership team with proven expertise

With a newly formed leadership team, LR is consistently driving the further development of its corporate strategy. As of 1 August 2025, Mr Jörg Körfer was appointed Chief Executive Officer (CEO). He brings extensive expertise in global direct sales from his many years of senior management positions at internationally operating companies, including Bofrost and Vorwerk. In addition, LR has strengthened its management team with the appointment of Mr Ante Franicevic, who serves as Interim Chief Financial Officer (CFO). Mr Franicevic contributes more than 20 years of senior management experience in finance at well-known retail and consumer brands such as Douglas, Jack Wolfskin and Metro.

Jörg Körfer, CEO of LR Health & Beauty SE, states: “As a newly formed leadership team, our clear goal is to continue LR’s success story as Europe’s leading social commerce company. Our Global Leader Convention in Berlin, marking the company’s 40th anniversary, and the Business Days in September provide an ideal opportunity to strengthen our engagement with our community members and to launch new business initiatives. Together with our distributors, we aim to make the company even stronger and more innovative, thereby ensuring sustainable success for LR in a challenging market environment.”

2024/2028 bond

Today, the Management Board of LR Health & Beauty SE resolved to initiate precautionary negotiations with the holders of the 2024/2028 bond (ISIN: NO0013149658) regarding a proposal to amend the bond terms and, if necessary, to request their consent to a waiver of the Leverage Covenant as at 30 September 2025. The background is a potential breach of the company’s obligation under Clause 13.2 of the bond terms, which requires the company to ensure that net debt in relation to EBITDA (the “Leverage Covenant”) does not exceed the threshold of 4.50:1 as at 30 September 2025. The Leverage Covenant was reduced from 4.75:1 to 4.50:1 as of 1 July 2025. Based on preliminary calculations, the Management Board currently assumes that the Leverage Covenant is unlikely to be met on the review date of 30 September 2025. This is due to EBITDA developing less favourably than expected, primarily due to increased or increasing costs in the areas of marketing and sales.

Outlook 2025

Furthermore, LR’s Management Board is adjusting the guidance for the 2025 financial year published on 25 April 2025. With regard to sales (revenue from goods sold), the Management Board now expects a stable development compared with the previous year. Previously, stable to moderately increasing sales had been forecast. EBITDA for the 2025 financial year is now expected to range between EUR 24.0 million and EUR 27.0 million – whereas the previous guidance anticipated significant EBITDA growth compared to the previous year’s figure of EUR 27.3 million. The revision of the EBITDA guidance is essentially due to increased or increasing costs in the areas of marketing and sales. This trend also continued in July, leading the Management Board to conclude that the previous guidance is unlikely to be achieved through catch-up effects or cost-saving measures.

The full report for the second quarter and the first half of 2025 will be available from 29 August 2025 on the corporate website: https://ir.lrworld.com/.

LR Group

Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard.

Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence. 

The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe. 

In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report.

LR currently has around 1,200 employees and hundreds of thousands of registered community members.

Contact:

PR contact: 
LR Health & Beauty SE    
Almut Kellermeyer     
Head of Corporate Communication     
Kruppstraße 55    
59227 Ahlen    
Phone: +49(0)2382 7658-106
E-mail: a.kellermeyer@LRworld.com
https://ir.lrworld.com/

IR contact: 
cometis AG
Thorben Burbach 
Unter den Eichen 7 | Gebäude D 
65195 Wiesbaden
Phone: +49(0)611 - 205855-23
Fax: +49(0)611 - 205855-66
E-mail: burbach@cometis.de